Atrovent and Allergic granulomatous angiitis - a phase IV clinical study of FDA data

Summary:

Allergic granulomatous angiitis is reported as a side effect among people who take Atrovent (ipratropium bromide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Singulair, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Allergic granulomatous angiitis when taking Atrovent. It is created by eHealthMe based on reports of 33,026 people who have side effects when taking Atrovent from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Allergic granulomatous angiitis?

Allergic granulomatous angiitis (allergic inflammation of a blood vessel or lymph duct) is found to be associated with 79 drugs and 216 conditions by eHealthMe. Check the latest studies of Allergic granulomatous angiitis.

On Jul, 04, 2026

33,026 people reported to have side effects when taking Atrovent.
Among them, 20 people (0.06%) have Allergic granulomatous angiitis.

Could Atrovent cause Allergic granulomatous angiitis?

Among these 20 people:

How long have people been on Atrovent when they have Allergic granulomatous angiitis? *

What is the gender of people who have Allergic granulomatous angiitis when taking Atrovent? *

female: 57.89 %
male: 42.11 %

What is the age of people who have Allergic granulomatous angiitis when taking Atrovent? *

What are other drugs people take besides Atrovent? *

What are other side effects people have besides Allergic granulomatous angiitis? *

Joint Pain: 7 people, 35.00%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 5 people, 25.00%
Fever: 3 people, 15.00%
Drug Ineffective: 3 people, 15.00%
Confusional State: 2 people, 10.00%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 10.00%
Haemodynamic Instability (disturbances in the blood movement in our body): 2 people, 10.00%
General Physical Health Deterioration (weak health status): 2 people, 10.00%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 10.00%
Neuritis (inflammation of nerve): 2 people, 10.00%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 15.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
Inflammation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and have Allergic granulomatous angiitis?

- Check whether Allergic granulomatous angiitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atrovent:

Atrovent (33,210 reports)

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Allergic granulomatous angiitis:

Allergic granulomatous angiitis (79 drugs)

Browse all the conditions that are associated with Allergic granulomatous angiitis:

Allergic granulomatous angiitis (216 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Atrovent) and Atrovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.